Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
24-26 June, 2025
Not Confirmed
Not Confirmed
10-12 June, 2025
Not Confirmed
Not Confirmed
11-12 June, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
24-26 June, 2025
Industry Trade Show
Not Confirmed
10-12 June, 2025
Industry Trade Show
Not Confirmed
11-12 June, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/alchem-nicselect-grants-customers-royalty-free-access-to-t-max-tech-for-3-in-1-vape-satisfaction-in-flavour-restricted-markets
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/excipient-market-overview-roquette-announces-restructuring-post-iff-pharma-buyout-who-fda-advance-regulatory-frameworks
27 May 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/05/27/3088570/0/en/Junshi-Biosciences-Announces-Ongericimab-s-sNDA-Approval-in-China.html
08 May 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/biodlink-congratulates-junshi-biosciences-on-ind-approval-of-js212-a-bispecific-adc-therapeutic-candidate-302449863.html
25 Apr 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/04/25/3068241/0/en/Junshi-Biosciences-Announces-the-sNDA-Approval-of-Toripalimab-for-the-1st-line-Treatment-of-Melanoma.html
28 Mar 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/03/29/3051707/0/en/Junshi-Biosciences-Announces-2024-Full-Year-Financial-Results-and-Provides-Corporate-Updates.html
26 Mar 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/03/27/3050235/0/en/Junshi-Biosciences-Announces-Toripalimab-s-Approval-in-Singapore.html
23 Mar 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/03/24/3047519/0/en/Junshi-Biosciences-Announces-Approval-of-sNDA-for-Toripalimab-in-Combination-with-Bevacizumab-for-1st-line-Treatment-of-Advanced-Hepatocellular-Carcinoma.html
ABOUT THIS PAGE